Third, among the 39 novel loci, there was only 1 locus (ARG1/MED23, Supplementary Fig. 17) at which the association between gene expression and T2D risk was significant in SMR and not rejected by HEIDI (Tables 2–3). This evidence concerns the gene ARG1 and type 2 diabetes mellitus.